Currently, this GGG tri-agonist is in phase two clinical trials to determine its efficacy in the treatment of obesity and type 2 diabetes
This decline correlates with visible aging signs, reduced wound healing capacity, and decreased tissue regeneration, providing the rationale for supplementation
Leaky Gut Symptoms Although the origin of leaky gut syndrome occurs in the gastrointestinal tract, the proximity of the GI tract to the immune system causes immune dysregulation and inflammation that can contribute to systemic symptoms
So the entire phase two programme was unsuccessful there were no side effects, but there was also no effect of the drug
If you struggle with obesity, insulin resistance, or metabolic conditions, this treatment addresses the root causes of weight gain